Concepedia

Aumreetam Dinabandhu

AD

Statistics

Publications

7

Citations

291

H-Index

7

Active since

2019

Affiliations

Johns Hopkins Medicine(Current)

Johns Hopkins University

University of Maryland, Baltimore

Sun Yat-sen University

China Medical University

Aumreetam Dinabandhu is an author at Johns Hopkins Medicine specializing in ophthalmology, retinal vascular disease, and angiogenesis.

ORCID

Publications per year

2019–2024

7

Publications

7

Angiopoietin-like 4 binds neuropilins and cooperates with VEGF to induce diabetic macular edema

Akrit Sodhi, Tao Ma, Deepak Menon et al. · Journal of Clinical Investigation · 2019 · 102 citations · Full text

, , +15

HIF-1α and HIF-2α redundantly promote retinal neovascularization in patients with ischemic retinal disease

Jing Zhang, Yaowu Qin, Mireya Martínez et al. · Journal of Clinical Investigation · 2021 · 93 citations · Full text

, , +9

Targeting hypoxia-inducible factors with 32-134D safely and effectively treats diabetic eye disease in mice

Jing Zhang, Deepti Sharma, Aumreetam Dinabandhu et al. · Journal of Clinical Investigation · 2023 · 32 citations · Full text

, , +16

ANGPTL4 influences the therapeutic response of patients with neovascular age-related macular degeneration by promoting choroidal neovascularization

Qin Yu, Aumreetam Dinabandhu, Xuan Cao et al. · JCI Insight · 2022 · 20 citations · Full text

, , +17

Aqueous proteins help predict the response of patients with neovascular age-related macular degeneration to anti-VEGF therapy

Xuan Cao, Jaron Castillo Sanchez, Aumreetam Dinabandhu et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 2022 · 17 citations · Full text

, , +17

1–5 of 7